{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:02:38Z","timestamp":1771927358096,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to document changes in the urine protein-to-creatinine ratio (UPC) in dogs with inflammatory protein-losing enteropathy (iPLE) undergoing glucocorticoid therapy and with no overt evidence of concurrent renal disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dogs with histologically confirmed iPLE, a serum albumin level of &amp;lt;2.0\u202fg\/dL, gastrointestinal signs for \u22652\u202fweeks, and no recent glucocorticoid use were prospectively enrolled at any of the four referral centers between 24 December 2020 and 25 May 2023. Dogs with azotemia, hepatopathy, urinary sediment abnormalities, or confirmed intestinal parasites were excluded. All dogs received prednisone or prednisolone (1\u202fmg\/kg BID), clopidogrel, and a new hypoallergenic or low-fat diet. Repeat urinalysis, UPC measurement, urine culture, blood pressure measurement, and serum chemistry analysis were performed after 1\u20132\u202fweeks (T1) and 2\u20133\u202fmonths (T2). Canine chronic enteropathy clinical activity index (CCECAI) scores were assessed at T0 and T1 for correlation with UPC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twelve dogs with iPLE were enrolled. Eight dogs were excluded due to comorbidities, loss to follow-up, or euthanasia. The median UPC increased from baseline (0.10) to T1 (0.25) and T2 (0.30). No dog had a UPC of &amp;gt;0.9. Mean CCECAI scores decreased from baseline (8.75) to T1 (3.08). UPC correlated with CCECAI at baseline [\n                      <jats:italic>\u03c1<\/jats:italic>\n                      (95%CI) 0.71 (0.22\u20130.91)], but not at follow-up [T1:\n                      <jats:italic>\u03c1<\/jats:italic>\n                      (95%CI) 0.04 (\u22120.55\u20130.60)] or changed from T0 to T1 [\n                      <jats:italic>\u03c1<\/jats:italic>\n                      (95%CI) 0.15 (\u22120.67\u20130.46)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glucocorticoids increase the UPC in dogs with iPLE to the same extent as has previously been shown in healthy dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical relevance<\/jats:title>\n                    <jats:p>Clinically significant proteinuria in iPLE dogs treated with glucocorticoids should prompt clinicians to consider alternative etiologies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2025.1751769","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:48:06Z","timestamp":1769150886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucocorticoids do not cause a clinically relevant elevation in the urine protein-to-creatinine ratio in dogs with inflammatory protein-losing enteropathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Cameron J.","family":"Wood","sequence":"first","affiliation":[{"name":"BluePearl Veterinary Partners","place":["Levittown, PA, United States"]},{"name":"Pacific Veterinary Emergency and Specialty Hospital","place":["Lafayette, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Chapman","sequence":"additional","affiliation":[{"name":"BluePearl Veterinary Partners","place":["Levittown, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Horowitz","sequence":"additional","affiliation":[{"name":"BluePearl Veterinary Partners","place":["Levittown, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2460\/ajvr.81.4.317","article-title":"Evaluation of dose-response effects of short-term oral prednisone administration on clinicopathologic and hemodynamic variables in healthy dogs","volume":"81","author":"Tinklenberg","year":"2020","journal-title":"Am J Vet Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1939-1676.1997.tb00086.x","article-title":"Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs","volume":"11","author":"Waters","year":"1997","journal-title":"J Vet Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1939-1676.2007.0039.x","article-title":"The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs","volume":"22","author":"Schellenberg","year":"2008","journal-title":"J Vet Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"106437","DOI":"10.1016\/j.domaniend.2020.106437","article-title":"Glucocorticoid metabolism in critically ill dogs (Canis lupus familiaris)","volume":"72","author":"Boag","year":"2020","journal-title":"Domest Anim Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2460\/ajvr.71.11.1387","article-title":"Quantitative and qualitative urine protein excretion in dogs with severe inflammatory response syndrome","volume":"71","author":"Raila","year":"2010","journal-title":"Am J Vet Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jsap.13503","article-title":"Point prevalence and clinical course of proteinuria in dogs with idiopathic non-erosive immune-mediated polyarthritis","volume":"63","author":"Barker","year":"2022","journal-title":"J Small Anim Pract"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cvsm.2011.02.002","article-title":"Protein-losing enteropathies in dogs","volume":"41","author":"Dossin","year":"2011","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/jvim.15408","article-title":"Comparative pathophysiology and management of protein-losing enteropathy","volume":"33","author":"Craven","year":"2019","journal-title":"J Vet Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cvsm.2020.09.010","article-title":"Canine protein-losing enteropathies and systemic complications","volume":"51","author":"Allenspach","year":"2021","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/jvim.15571","article-title":"Diagnostic features, treatment, and outcome of dogs with inflammatory protein-losing enteropathy","volume":"33","author":"Salavati Schmitz","year":"2019","journal-title":"J Vet Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.5455\/OVJ.2022.v12.i4.21","article-title":"Alterations of selected serum biochemical and urinary parameters in dogs with chronic enteropathy","volume":"12","author":"Gori","year":"2022","journal-title":"Open Vet J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jsap.12625","article-title":"Dietary management of presumptive protein-losing enteropathy in Yorkshire terriers","volume":"58","author":"Rudinsky","year":"2017","journal-title":"J Small Anim Pract"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jvim.14669","article-title":"Histopathologic characteristics of intestinal biopsy samples from dogs with chronic inflammatory enteropathy with and without hypoalbuminemia","volume":"31","author":"Wennogle","year":"2017","journal-title":"J Vet Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1590\/S0100-736X2013001000011","article-title":"Proteinuria in dogs with pituitary-dependent hyperadrenocorticism","volume":"33","author":"Cavalcante","year":"2013","journal-title":"Pesqui Vet Bras"},{"key":"ref15","year":""},{"key":"ref16","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.cimid.2021.101624","article-title":"Clinical and microbiological characterization of subclinical bacteriuria and sporadic bacterial cystitis in dogs with spontaneous hypercortisolism","volume":"75","author":"Machado","year":"2021","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jvim.15720","article-title":"Clinical characteristics of dogs with food-responsive protein-losing enteropathy","volume":"34","author":"Nagata","year":"2020","journal-title":"J Vet Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1939-1676.2010.0474.x","article-title":"Comparison of ultrasonic doppler flow monitor, oscillometric, and direct arterial blood pressure measurements in ill dogs","volume":"24","author":"Acierno","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1939-1676.2007.tb03012.x","article-title":"Chronic enteropathies in dogs: evaluation of risk factors for negative outcome","volume":"21","author":"Allenspach","year":"2007","journal-title":"J Vet Intern Med"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1751769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:10:23Z","timestamp":1771924223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1751769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":19,"alternative-id":["10.3389\/fvets.2025.1751769"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1751769","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1751769"}}